| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/24/2012 | CA2498559C Indole derivatives or benzimidazole derivatives for modulating i.kappa.b kinase |
| 01/19/2012 | WO2012009446A1 Novel pyrimidinecarboxamide derivatives |
| 01/19/2012 | WO2012008564A1 Nitrogenated aromatic heterocyclic ring derivative |
| 01/19/2012 | WO2012008563A1 Nitrogenated aromatic heterocyclic ring derivative |
| 01/19/2012 | WO2012008549A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012008468A1 Complex compound and optical recording medium containing same |
| 01/19/2012 | WO2012007836A1 Pyridine compounds as sodium channel blockers |
| 01/19/2012 | WO2012007426A1 Azoline substituted isoxazoline benzamide compounds for combating animal pests |
| 01/19/2012 | WO2012006953A1 Oxazine derivatives and their use in the treatment of neurological disorders |
| 01/19/2012 | WO2011138751A3 Heterocyclic derivatives as alk inhibitors |
| 01/19/2012 | WO2011109679A3 Inhibitors of 5-lipoxygenase |
| 01/19/2012 | WO2011103289A3 Imidazole-2, 4-dione inhibitors of casein kinase 1 |
| 01/19/2012 | WO2011102660A3 A novel 5-membered heterocycle derivatives and manufacturing process thereof |
| 01/19/2012 | US20120016449 Phototherapy devices and methods comprising substituted carbazole compounds |
| 01/19/2012 | US20120016131 Compositions and methods for inhibition of the jak pathway |
| 01/19/2012 | US20120016124 Serotonin reuptake inhibitors |
| 01/19/2012 | US20120016122 Compositions and methods for inhibition of the jak pathway |
| 01/19/2012 | US20120016118 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| 01/19/2012 | US20120015991 Polycyclic antagonists of lysophosphatidic acid receptors |
| 01/19/2012 | US20120015988 Sulfone Compounds Which Modulate The CB2 Receptor |
| 01/19/2012 | US20120015980 Anthranilic diamide derivatives |
| 01/19/2012 | US20120015976 Autotaxin inhibitors |
| 01/19/2012 | US20120015958 1-(4-ureidobenzoyl)piperazine derivatives |
| 01/19/2012 | US20120015957 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 01/19/2012 | US20120015954 Therapeutic agents useful for treating pain |
| 01/19/2012 | US20120015950 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof |
| 01/19/2012 | US20120015946 Insecticidal compounds |
| 01/19/2012 | US20120015944 Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 01/19/2012 | US20120015943 Substituted hydroxamic acids and uses thereof |
| 01/19/2012 | US20120015942 Substituted hydroxamic acids and uses thereof |
| 01/19/2012 | US20120015937 Kinase Inhibitors And Their Uses |
| 01/19/2012 | US20120015932 Pyrazole Derivatives Used as CCR4 Receptor Antagonists |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015926 Compounds for the treatment of inflammatory disorders |
| 01/19/2012 | US20120015908 Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives |
| 01/19/2012 | US20120015907 Furopyridine compounds and uses thereof |
| 01/19/2012 | US20120015159 Cyclic carbamate compounds useful in energy-curable compositions |
| 01/19/2012 | US20120015052 P2x3 receptor antagonists for treatment of pain |
| 01/19/2012 | US20120014997 Aryl sulfonamides |
| 01/19/2012 | US20120014914 Inhibitors of serine proteases, particularly hcv ns3-ns4a proteases |
| 01/19/2012 | CA2771928A1 Oxazine derivatives and their use in the treatment of neurological disorders |
| 01/18/2012 | EP2407451A1 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 01/18/2012 | EP2406256A1 Compounds for the treatment of metabolic disorders |
| 01/18/2012 | EP2406255A1 4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases |
| 01/18/2012 | EP2406254A2 Intermediate compound for synthesizing pharmaceutical agent and production method thereof |
| 01/18/2012 | EP2406250A1 Inhibitors of akt activity |
| 01/18/2012 | EP2406247A1 Compounds for the treatment of metabolic disorders |
| 01/18/2012 | EP2406243A1 Benzofuran derivatives |
| 01/18/2012 | EP2406226A1 Substituted nicotinamides as kcnq2/3 modulators |
| 01/18/2012 | EP2321306B1 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 01/18/2012 | EP2220076B1 Inhibitors of human immunodeficiency virus replication |
| 01/18/2012 | EP1919907B9 Heterocyclic compound |
| 01/18/2012 | EP1884511B1 Aromatic ether compounds,preparation and usage thereof |
| 01/18/2012 | EP1831202B1 Pyrrolinidium derivatives as m3 muscarinic receptors |
| 01/18/2012 | CN1976706B Inhibition of FGFR3 and treatment of multiple myeloma |
| 01/18/2012 | CN1950351B 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 01/18/2012 | CN102325767A 7-phenoxychroman carboxylic acid derivatives |
| 01/18/2012 | CN102325765A Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators |
| 01/18/2012 | CN102325763A Sulfamides as TRPM8 modulators |
| 01/18/2012 | CN102325759A Substituted amidine compounds for combating animal pests |
| 01/18/2012 | CN102325754A Cyclic compound having hetero atom |
| 01/18/2012 | CN102325752A Carbazole and carboline kinase inhibitors |
| 01/18/2012 | CN102325750A Sulfonamides as trpm8 modulators |
| 01/18/2012 | CN102320988A 4-(4-amion phenyl)-3-morpholone intermediate amide and synthesis method and application thereof |
| 01/18/2012 | CN101824031B Chiral oxazoline and use thereof |
| 01/18/2012 | CN101497609B Process for preparing furaltadone hydrochloride |
| 01/18/2012 | CN101346373B 2,2',6,6'-four oxazolines biphenyl ligand and preparation method thereof |
| 01/18/2012 | CN101304969B Benzene derivative or salt thereof |
| 01/18/2012 | CN101163692B Heterocyclic substituted piperazines with cxcr3 antagonist activity |
| 01/17/2012 | US8097759 Inflammatory cytokine release inhibitor |
| 01/17/2012 | US8097730 Bicyclic heterocycles useful as selective androgen receptor modulators |
| 01/17/2012 | US8097629 Dihydropyridinone derivatives |
| 01/17/2012 | US8097624 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
| 01/17/2012 | US8097623 1-Aryl-or heteroaryl-3-aryl-or heteroarylindole-2-carboxylic acids or esters: e.g., 5-(4-tert-Butylphenyl)-1,3-bis(4-isopropoxyphenyl)-indole-2-carboxylic acid; inhibition of the activity of microsomal prostaglandin E synthase-1, leukotriene C4 and/or 5-lipoxygenase-activating protein; analgesics |
| 01/17/2012 | US8097622 Morpholinopurine derivatives |
| 01/17/2012 | US8097620 Diazaquinolones that inhibit prolyl hydroxylase activity |
| 01/17/2012 | US8097619 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 01/17/2012 | US8097617 Organic compounds |
| 01/17/2012 | US8097611 Sulfonyl-derivatives as novel or histone deacetylase |
| 01/17/2012 | US8097610 Derivative having PPAR agonistic activity |
| 01/17/2012 | CA2652071C Method for producing isoxazoline-3-yl-acyl benzene |
| 01/17/2012 | CA2626767C Heterocyclic substituted pyridine derivatives and antifungal agent containing same |
| 01/17/2012 | CA2494846C Arylamides |
| 01/17/2012 | CA2473986C Indazole compounds useful as protein kinase inhibitors |
| 01/17/2012 | CA2385456C 9-(piperazinylalkyl) carbazoles as bax-modulators |
| 01/12/2012 | WO2012006473A1 Compounds and methods for inhibiting phosphate transport |
| 01/12/2012 | WO2012006203A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors |
| 01/12/2012 | WO2012006055A2 Compounds and methods for the treatment or prevention of flavivirus infections |
| 01/12/2012 | WO2012005299A1 Ros tyrosine kinase inhibitor |
| 01/12/2012 | WO2012004722A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 01/12/2012 | WO2012004604A1 Tetrazole compounds as calcium channel blockers |
| 01/12/2012 | WO2012004375A1 Bisaryl (thio)morpholine derivatives as s1p modulators |
| 01/12/2012 | WO2012004245A1 Crystalline form of rivaroxaban dihydrate |
| 01/12/2012 | WO2012004207A1 (3 -methylpyrrolidin- 3 - yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists |
| 01/12/2012 | WO2012003642A1 Fused tricyclic compounds and use thereof for treating viral diseases |
| 01/12/2012 | WO2011111971A3 Method for preparing (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives |
| 01/12/2012 | WO2010135524A8 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases |
| 01/12/2012 | US20120010222 Gyrase Inhibitors and Uses Thereof |
| 01/12/2012 | US20120010219 Salvinorin derivatives and uses thereof |
| 01/12/2012 | US20120010212 Methyl-pyrrolidine ether derivatives |